Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FMT in Adults With Atopic Dermatitis
NCT04613037Phase 1Completed
- Sponsor
- Tel Aviv Sourasky Medical Center
- Start
- Nov 2017
- Primary completion
- Jul 2019
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
Phase 1, single-blind, single-arm trial of allogeneic fecal microbiota in atopic dermatitis (AD), sponsored by Tel Aviv Sourasky Medical Center. Primary endpoint: Scoring Atopic Dermatitis. Started Nov 2017; status: completed.
02
Drugs
allogeneic fecal microbiota
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT04613037.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04613037.